Possible anaphylactic reaction to taxus stent: a case report.
We report a patient who experienced an anaphylactic reaction during coronary artery stenting. Immediately after a polymer-based paclitaxel-eluting stent (Taxus, Boston-Scientific) is deployed, the patient developed profound hypotension and an erythematous rash. The case complicated with coronary spasm and a new thrombus formation making a second stent implantation necessary. The reaction was successfully reversed with epinephrine, steroid, antihistaminic, a 9-hr infusion of dopamine, and intraaortic balloon counterpulsation.
Turkoglu
Sedat
S
Department of Cardiology, Gazi University School of Medicine, Ankara, Turkey.
Simsek
Vedat
V
Abaci
Adnan
A
D000707:Anaphylaxis / Q000139:chemically induced*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation*; D020099:Coated Materials, Biocompatible / Q000009:adverse effects*; D017023:Coronary Angiography; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000601:surgery*; D017239:Paclitaxel / Q000009:adverse effects*; D015607:Stents / Q000009:adverse effects*
D000972:Antineoplastic Agents, Phytogenic; D020099:Coated Materials, Biocompatible; D017239:Paclitaxel